Dr Lal Pathlabs Ltd Share Price
(LALPATHLAB)
₹2777.8
as on 04:01PM, 29 Apr 2025
Dr Lal Pathlabs Ltd Performance
Day's Low
Day's High
₹2,752.6Day's Price Range₹2,851.652 Week's Low
52 Week's High
₹2,201.252-Week Price Range₹3,653.95
| Returns % | |
| 1 Month Return | + 17.18 % |
| 3 Month Return | + 1.91 % |
| 1 Year Return | + 19.8 % |
| Market Stats | |
| Previous Close | ₹2,811.70 |
| Open | ₹2,835.00 |
| Volume | 2.13L |
| Upper Circuit | ₹3,374.00 |
| Lower Circuit | ₹2,249.40 |
| Market Cap | ₹23,503.49Cr |
Dr Lal Pathlabs Ltd Fundamentals
P/E Ratio
48.08
PEG Ratio
3.11
Market Cap
₹23,503.49 Cr
P/B Ratio
9.94
EPS
43.4
Dividend Yield
0.8
Sector
Healthcare
ROE
21.42
Mutual Fund Holdings of Dr Lal Pathlabs Ltd
Dr Lal Pathlabs Ltd Analyst Rating
based on 23 analysts
62.50%
Buy
8.33%
Hold
29.17%
Sell
Based on 23 analysts offering long term price targets for Dr Lal Pathlabs Ltd. An average target of ₹3085.91
Source: S&P Global Market Intelligence
Dr Lal Pathlabs Ltd Share analysis
Dr Lal Pathlabs Ltd price forecast by 23 analysts
Upside of9.75%
High
₹3770
Target
₹3085.91
Low
₹2110
Dr Lal Pathlabs Ltd target price ₹3085.91, a slight upside of 9.75% compared to current price of ₹2777.8. According to 23 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Dr Lal Pathlabs Ltd revenue growth forecast
Expected growth rate Q1, FY2027:38.87%
Forecast
Actual
Including amortisation and stock based compensations
Dr Lal Pathlabs Ltd EPS growth forecast
EPS estimate Q1, FY2027:62.33%
Forecast
Actual
Source: S&P Global Market Intelligence
Key events for Dr Lal Pathlabs Ltd
Dr Lal PathLabs Targets Growth and Margin Stability - 29 Apr, 2025
Dr Lal PathLabs aims for a 27% margin in FY26 while planning to expand its network by opening 15-20 new labs. The company reported a cash balance of INR 12.3 billion for future investments and M&A opportunities.Dr Lal Pathlabs Reports Strong Q4 Amid Margin Concerns - 28 Apr, 2025
Dr Lal Pathlabs reported a 10.5% rise in Q4 net sales and an 83.2% increase in profit. However, the stock fell due to mixed brokerage outlooks and anticipated margin pressures from expansion plans.Dr Lal PathLabs Reports Strong Q4 Results and Dividend - 25 Apr, 2025
Dr Lal PathLabs announced a robust Q4FY25 with an 83% profit increase to ₹155 crore, alongside a ₹6 final dividend. Growth driven by expanded testing volumes and geographic reach.Dr Lal PathLabs Announces Upcoming Dividend Consideration - 18 Apr, 2025
Dr Lal PathLabs will hold a board meeting on April 25, 2025, to discuss quarterly results and consider recommending a final dividend for FY25. The company previously declared a third interim dividend of Rs 6 per share in January 2025, following a strong Q3 performance with a 19% increase in profit after tax.Dr. Lal PathLabs Launches Advanced Amyloidosis Test - 15 Apr, 2025
Dr. Lal PathLabs has introduced a breakthrough test for amyloidosis, becoming the first diagnostic chain in South Asia to offer this advanced service, enhancing diagnostic accuracy and treatment options.
Insights on Dr Lal Pathlabs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, LALPATHLAB stock has moved up by 1.8%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 96.7 Cr → 154.8 Cr (in ₹), with an average increase of 37.5% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.25% to 12.84% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 621.8 Cr → 628.4 Cr (in ₹), with an average increase of 1.1% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 5.82% to 5.84% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 165.8% return, outperforming this stock by 157.6%
- NO EFFECT
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 52.4% return, outperforming this stock by 32.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 53.91% of holdings in Mar 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 26.82% to 23.91% in Mar 2025 quarter
Dr Lal Pathlabs Ltd Financials
Dr Lal Pathlabs Ltd Index Inclusions
Dr Lal Pathlabs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 53.91% | 0.00 | |
| Foreign Institutions | 23.91% | 0.00 | |
| Mutual Funds | 12.84% | 0.00 | |
| Retail Investors | 5.84% | 0.00 | |
| Others | 3.51% | 0.00 |
Dr Lal Pathlabs Ltd Key Indicators
Dr Lal Pathlabs Ltd Valuation
Dr Lal Pathlabs Ltd in the last 5 years
Lowest (37.51x)
November 16, 2018
Today (48.08x)
April 28, 2025
Industry (101.14x)
April 28, 2025
Highest (95.62x)
November 5, 2020
Dr Lal Pathlabs Ltd Earnings and Dividends
Dr Lal Pathlabs Ltd Earnings Results
Dr Lal Pathlabs Ltd’s net profit jumped 83.2% since last year same period to ₹154.80Cr in the Q4 2024-2025. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated 60.08% jump in its net profits since last 3-months.
Read More about Earnings ResultsDr Lal Pathlabs Ltd Dividends January,2025
In the quarter ending December 2024, Dr Lal Pathlabs Ltd has declared dividend of ₹6 - translating a dividend yield of 1.30%.
Read More about Dividends
Dr Lal Pathlabs Ltd Technicals Summary
Bearish
Neutral
Bullish
Dr Lal Pathlabs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Dr Lal Pathlabs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| HOLD | ₹23,503.49 Cr | 15.68% | 0.55 | ₹362 Cr | ₹2,226 Cr | |
| HOLD | ₹33,784.17 Cr | 101.62% | 0.67 | ₹168 Cr | ₹5,040 Cr | |
| HOLD | ₹60,090.98 Cr | 17.89% | 0.56 | ₹1,811 Cr | ₹12,667 Cr | |
| BUY | ₹10,656.72 Cr | 13.49% | 0.64 | ₹119 Cr | ₹547 Cr | |
| BUY | ₹4,833.53 Cr | 15.31% | 0.54 | ₹69 Cr | ₹571 Cr |
About Dr Lal Pathlabs Ltd
The company's top products include pathology tests, imaging tests, and preventive health check-ups. Its popular brands include Dr Lal PathLabs, Lal PathLabs, and Lal PathLabs Diagnostics. Dr Lal PathLabs Ltd has over 2000 labs across India, with more than 2000 collection centers, and over 20000 trained professionals. The company is also present in Nepal, Sri Lanka, and Bangladesh.
Dr Lal PathLabs Ltd is committed to providing quality healthcare services and products to its customers. It is ISO 9001:2015 certified and has been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL).
Revenue: ₹602.60Cr as on March 2025 (Q1 25)
Net Profit: ₹155.50Cr as on March 2025 (Q1 25)
Listing date: 23 Dec, 2015
Chairperson Name: Arvind Lal
| Organisation | Dr Lal Pathlabs Ltd |
| Headquarters | Gurgaon |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
FAQs on Dr Lal Pathlabs Ltd
What is Dr Lal Pathlabs Ltd price today?
Dr Lal Pathlabs Ltd share price today stands at ₹2777.8, Open: ₹2835, Previous Close: ₹2811.7, High: ₹2851.6, Low: ₹2752.6, 52 Week High: ₹3653.95, 52 Week Low: ₹2201.2.
How to Buy Dr Lal Pathlabs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Dr Lal Pathlabs Ltd shares
What are today's traded volumes of Dr Lal Pathlabs Ltd?
Today's traded volume of Dr Lal Pathlabs Ltd(LALPATHLAB) is 2.13L.
What is today's market capitalisation of Dr Lal Pathlabs Ltd?
Today's market capitalisation of Dr Lal Pathlabs Ltd(LALPATHLAB) is ₹23503.49Cr.
What is the 52 Week High and Low Range of Dr Lal Pathlabs Ltd?
How much percentage Dr Lal Pathlabs Ltd is down from its 52 Week High?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2777.8. It is down -23.98% from its 52 Week High price of ₹3653.95
How much percentage Dr Lal Pathlabs Ltd is up from its 52 Week low?
Dr Lal Pathlabs Ltd (LALPATHLAB) share price is ₹2777.8. It is up 26.19% from its 52 Week Low price of ₹2201.2